Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Profile and Laboratory Finding of DFU From Tertiary Hospitals in Bali

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03939000
Recruitment Status : Completed
First Posted : May 6, 2019
Last Update Posted : May 6, 2019
Sponsor:
Information provided by (Responsible Party):
Hendry Irawan, Udayana University

Brief Summary:
The investigators want to obtain the clinical profile, hematological profile, and biochemical profile from diabetic foot ulcer (DFU) patient.

Condition or disease
Diabetic Foot Ulcer Type 2 Diabetes Mellitus Laboratory Problem Physical Findings.Skin Ulcer

Detailed Description:

This study is a retrospective descriptive study reviewing the medical records of diabetic foot patients who were admitted to Sanglah General Hospital for surgical procedure. Sanglah General Hospital is a provincial hospital located in Denpasar, Bali, which is the central referral hospital in Bali and Nusa Tenggara islands as known as a tertiary hospital.

All DFU patients who underwent surgical procedures in Sanglah General Hospital operating theatre were included in the study. All patient medical records were provided by our hospital information center system. A diagnosis of diabetes mellitus was defined and confirmed from ICD (International Classification of Diseases)-10 code E11.622 for "Type 2 Diabetes Mellitus with other skin ulcers".

Data which we collected from the hospital information center system were further addressed into different aspects, which comprised of personal data, DFU severity, diabetes mellitus duration, ulcer duration, treatment procedures, and laboratory results. Based on our main objective of this study, we divide the laboratory results into two groups, hematological and blood chemistry profile. The variables selected in the hematological profile were hemoglobin, hematocrit, leukocyte and differential counts, and platelet. The variables which were included in blood chemistry profile are alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum albumin, random blood glucose, glycated hemoglobin (HbA1c), blood urea nitrogen (BUN), serum creatinine, serum sodium, serum potassium, prothrombin time (PTT), activated partial thromboplastin time (APTT), and international normalized ratio (INR).

The protocol of DFU management in our hospital included diagnosis and treatment of infection (local and systemic), assessment of patient's diabetic status, treatment of infection, diabetes mellitus, and wound care, and also surgical procedure, such as sharp debridement and amputations. The procedures were classified into five categories, consist of debridement, amputation of the fingers, transmetatarsal amputation, amputation below the knee, and amputation above the knee. DFU severity is classified into five different grades, based on Wagner's diabetic foot classification. In our hospital, patients with diabetic foot problems were evaluated and treated by a team consisting of surgeons, endocrinologists, microbiologists, rehabilitation specialists, nutritionists, and nurses.

For the statistical analyses, variables were assessed using the program IBM SPSS statistics version 23.0 for Windows (IBM Corporation, New York, USA). All numerical data were summarized as mean ± standard deviation, and categorical variables were summarized as frequency and percentage. Our method is about to use every available data to descriptively picture laboratory characteristics in DFU patients.

Layout table for study information
Study Type : Observational
Actual Enrollment : 113 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Clinical Profile and Laboratory Finding of Diabetic Foot Ulcers From Tertiary Hospitals in Bali
Actual Study Start Date : March 2016
Actual Primary Completion Date : December 2018
Actual Study Completion Date : January 2019

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Age [ Time Frame: Before surgery ]
    Age in years

  2. Diabetes mellitus duration [ Time Frame: Before surgery ]
    Diabetes mellitus duration in years

  3. Foot ulcer duration [ Time Frame: Before surgery ]
    Foot ulcer duration in weeks

  4. Gender [ Time Frame: Before surgery ]
    Gender is classified to male and female

  5. Foot affected [ Time Frame: Before surgery ]
    Foot affected is classified to right foot, left foot, and bilateral

  6. Wagner classification [ Time Frame: Before surgery ]
    Wagner classification is classified to grade 1, grade 2, grade 3, grade 4, and grade 5

  7. Surgical procedure [ Time Frame: After surgery ]
    Surgical procedure is classified to debridement, finger amputation, transmetatarsal amputation, below the knee amputation, and above the knee amputation

  8. Hemoglobin [ Time Frame: Before surgery ]
    Hemoglobin in g/dL

  9. Hematocrit [ Time Frame: Before surgery ]
    Hematocrit in %

  10. Leukocyte [ Time Frame: Before surgery ]
    Leukocyte in 10^9/L

  11. Basophil [ Time Frame: Before surgery ]
    Basophil in 10^9/L

  12. Eosinophil [ Time Frame: Before surgery ]
    Eosinophil in 10^9/L

  13. Neutrophil [ Time Frame: Before surgery ]
    Neutrophil in 10^9/L

  14. Lymphocyte [ Time Frame: Before surgery ]
    Lymphocyte in 10^9/L

  15. Monocyte [ Time Frame: Before surgery ]
    Monocyte in 10^9/L

  16. Platelet [ Time Frame: Before surgery ]
    Platelet in 10^9/L

  17. Alanine aminotransferase [ Time Frame: Before surgery ]
    Alanine aminotransferase (ALT) in U/L

  18. Aspartate aminotransferase [ Time Frame: Before surgery ]
    Aspartate aminotransferase (AST) in U/L

  19. Serum albumin [ Time Frame: Before surgery ]
    Serum albumin in g/dL

  20. Random blood glucose [ Time Frame: Before surgery ]
    Random blood glucose in mg/dL

  21. Glycated hemoglobin [ Time Frame: Before surgery ]
    Glycated hemoglobin (HbA1c) in %

  22. Blood urea nitrogen [ Time Frame: Before surgery ]
    Blood urea nitrogen (BUN) in mg/dL

  23. Serum creatinine [ Time Frame: Before surgery ]
    Serum creatinine in mg/dL

  24. Serum sodium [ Time Frame: Before surgery ]
    Serum sodium in mmol/L

  25. Serum potassium [ Time Frame: Before surgery ]
    Serum potassium in mmol/L

  26. Prothrombin time [ Time Frame: Before surgery ]
    Prothrombin time (PT) in seconds

  27. Activated partial thromboplastin time [ Time Frame: Before surgery ]
    Activated partial thromboplastin time (APTT) in seconds

  28. International normalized ratio [ Time Frame: Before surgery ]

    International normalized ratio (INR) has no units (it is a ratio) and is determined to decimal place. INR formula is (patient PT/mean normal PT)ISI.

    ISI stands for International Sensitivity Index




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All DFU patients who underwent surgical procedures in Sanglah General Hospital operating theatre.
Criteria

Inclusion Criteria:

  • DFU patients who underwent surgical procedures in Sanglah General Hospital operating theatre.

Exclusion Criteria:

  • DFU patients without surgical intervention.
Publications:
Kayssi A, Rogers LC, Neville RF. General Considerations in Diabetic Foot Ulcers. In: Sidawy AN and Perler BA, editors. Rutherford's Vascular Surgery and Endovascular Therapy. 9th ed. Philadelphia: Elsevier Inc; 2019. p.1514-26.
Pemayun TGD, Naibaho RM. Diabetes Management Diabetic Foot Ulcer Registry at a Tertiary Care Hospital in Semarang, Indonesia: an Overview of its Clinical Profile and Management Outcome. J Clin Diabetes Pract. 2016;1:111.
Leong M, Murphy KD, Phillips LG. Wound Healing. In: Townsend Jr CM, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 20th ed. Philadelphia: Elsevier Inc; 2017. p.130-62.
Barbul A, Efron DT, Kavalukas SL. Wound Healing. In: Brunicardi FC, Andersen DK, Billiar TR, et al, editors. Schwartz Principles of Surgery. 10th ed. New York: McGraw Hill Education; 2015. p. 241-71.
Powers AC. Diabetes Mellitus. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw Hill Education; 2011. p.2968-2970.
Tarigan TJE, Yunir E, Subekti I, Pramono LA, Martina D. Profile and analysis of diabetes chronic complications in Outpatient Diabetes Clinic of Cipto Mangunkusumo Hospital, Jakarta. Med J Indones. 2015;24:156-62.
Bowker JH. Minor and Major Lower-Limb Amputations and Disarticulations in Patients with Diabetes Mellitus. In: Bowker JH, Pfeifer MA. Levin and O'Neal's the Diabetic Foot. 7th ed. Philadelphia: Elsevier Inc; 2008. p.403-28.
Kahraman C, Yümün G, Kahraman NK, Namdar ND, Cosgun S. Neutrophil-to-lymphocyte ratio in diabetes mellitus patients with and without diabetic foot ulcer. Eur J Med Sci. 2014;1:8-13.
Semadi IN, Irawan H. Blood glucose and lipid profile in patients with diabetic foot ulcer that underwent hyperbaric oxygen therapy. Bali Med J. 2017;6:405-8.
Wounds International. International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. London: Wounds International A division of Schofield Healthcare Media Limited Enterprise House; 2013.

Layout table for additonal information
Responsible Party: Hendry Irawan, General Surgeon, Udayana University
ClinicalTrials.gov Identifier: NCT03939000    
Other Study ID Numbers: Profile_DFU
First Posted: May 6, 2019    Key Record Dates
Last Update Posted: May 6, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Hendry Irawan, Udayana University:
clinical profile
diabetic foot ulcer
laboratory finding
tertiary hospital
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetic Foot
Foot Ulcer
Skin Ulcer
Diabetes Mellitus, Type 2
Ulcer
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pathologic Processes
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Leg Ulcer
Skin Diseases
Diabetes Complications
Diabetic Neuropathies
Foot Diseases